Acquisition Gives Investors’ Circle Big Exit

Concerned about the shortage of exit opportunities for impact investments?

Here’s one: Early-stage impact investing network Investors’ Circle announced an exit from its portfolio this week, as Boston Heart Diagnostics, a US-based health services firm with a proprietary blood test was acquired by Luxembourg-based Eurofins Scientific for  $140 million.

“We were compelled by the social mission of saving lives, the well-conceived business model, and an attractive valuation,” said Sky Lance, Investors’ Circle member and managing principal of the Patient Capital Collaborative fund. Investors’ Circle has deployed $185 million into more than 290 companies.

Related News

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright 2017 IMPACT ALPHA. All RIGHTS RESERVED.

ia-logo-footer
Register Now!
Enjoy FREE access to
ImpactAlpha: Investment News for a Sustainable Edge
Daily news, featured articles, newsletters, podcasts, webinars, special events and more!